213 related articles for article (PubMed ID: 15102693)
1. Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma.
Yamamoto S; Tomita Y; Hoshida Y; Morooka T; Nagano H; Dono K; Umeshita K; Sakon M; Ishikawa O; Ohigashi H; Nakamori S; Monden M; Aozasa K
Clin Cancer Res; 2004 Apr; 10(8):2846-50. PubMed ID: 15102693
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of activated AKT expression in soft-tissue sarcoma.
Tomita Y; Morooka T; Hoshida Y; Zhang B; Qiu Y; Nakamichi I; Hamada K; Ueda T; Naka N; Kudawara I; Aozasa K
Clin Cancer Res; 2006 May; 12(10):3070-7. PubMed ID: 16707604
[TBL] [Abstract][Full Text] [Related]
3. Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma.
Chadha KS; Khoury T; Yu J; Black JD; Gibbs JF; Kuvshinoff BW; Tan D; Brattain MG; Javle MM
Ann Surg Oncol; 2006 Jul; 13(7):933-9. PubMed ID: 16788754
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated Akt/PKB controls cell growth and apoptosis in intraductal papillary-mucinous tumor and invasive ductal adenocarcinoma of the pancreas.
Semba S; Moriya T; Kimura W; Yamakawa M
Pancreas; 2003 Apr; 26(3):250-7. PubMed ID: 12657951
[TBL] [Abstract][Full Text] [Related]
5. PTEN-positive and phosphorylated-Akt-negative expression is a predictor of survival for patients with advanced endometrial carcinoma.
Uegaki K; Kanamori Y; Kigawa J; Kawaguchi W; Kaneko R; Naniwa J; Takahashi M; Shimada M; Oishi T; Itamochi H; Terakawa N
Oncol Rep; 2005 Aug; 14(2):389-92. PubMed ID: 16012720
[TBL] [Abstract][Full Text] [Related]
6. Frequent activation of AKT2 kinase in human pancreatic carcinomas.
Altomare DA; Tanno S; De Rienzo A; Klein-Szanto AJ; Tanno S; Skele KL; Hoffman JP; Testa JR
J Cell Biochem; 2002; 87(4):470-6. PubMed ID: 14735903
[TBL] [Abstract][Full Text] [Related]
7. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
[TBL] [Abstract][Full Text] [Related]
8. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
[TBL] [Abstract][Full Text] [Related]
9. Clinical implication of Sox9 and activated Akt expression in pancreatic ductal adenocarcinoma.
Xia S; Feng Z; Qi X; Yin Y; Jin J; Wu Y; Wu H; Feng Y; Tao M
Med Oncol; 2015 Jan; 32(1):358. PubMed ID: 25428381
[TBL] [Abstract][Full Text] [Related]
10. CCDC88A, a prognostic factor for human pancreatic cancers, promotes the motility and invasiveness of pancreatic cancer cells.
Tanouchi A; Taniuchi K; Furihata M; Naganuma S; Dabanaka K; Kimura M; Watanabe R; Kohsaki T; Shimizu T; Saito M; Hanazaki K; Saibara T
J Exp Clin Cancer Res; 2016 Dec; 35(1):190. PubMed ID: 27919290
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma.
Yamamoto S; Tomita Y; Hoshida Y; Nagano H; Dono K; Umeshita K; Sakon M; Ishikawa O; Ohigashi H; Nakamori S; Monden M; Aozasa K
Ann Surg Oncol; 2004 Feb; 11(2):165-72. PubMed ID: 14761919
[TBL] [Abstract][Full Text] [Related]
12. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
13. High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker.
Hiraoka K; Hida Y; Miyamoto M; Oshikiri T; Suzuoki M; Nakakubo Y; Shinohara T; Itoh T; Shichinohe T; Kondo S; Kasahara N; Katoh H
Int J Cancer; 2002 May; 99(3):418-23. PubMed ID: 11992411
[TBL] [Abstract][Full Text] [Related]
14. Phosph-Akt1 expression is associated with a favourable prognosis in pancreatic cancer.
Liu J; Cheng Sun SH; Sun SJ; Huang C; Hu HH; Jin YB; Qiu ZJ
Ann Acad Med Singap; 2010 Jul; 39(7):548-7. PubMed ID: 20697673
[TBL] [Abstract][Full Text] [Related]
15. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
Liang JJ; Wang H; Rashid A; Tan TH; Hwang RF; Hamilton SR; Abbruzzese JL; Evans DB; Wang H
Clin Cancer Res; 2008 Nov; 14(21):7043-9. PubMed ID: 18981001
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of NEDD9, E-cadherin and γ-catenin and their prognostic significance in pancreatic ductal adenocarcinoma (PDAC).
Radulović P; Krušlin B
Bosn J Basic Med Sci; 2018 Aug; 18(3):246-251. PubMed ID: 29924959
[TBL] [Abstract][Full Text] [Related]
17. Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells.
Verma A; Guha S; Wang H; Fok JY; Koul D; Abbruzzese J; Mehta K
Clin Cancer Res; 2008 Apr; 14(7):1997-2005. PubMed ID: 18381937
[TBL] [Abstract][Full Text] [Related]
18. Expression and activity of SRC regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis.
Trevino JG; Summy JM; Gray MJ; Nilsson MB; Lesslie DP; Baker CH; Gallick GE
Cancer Res; 2005 Aug; 65(16):7214-22. PubMed ID: 16103072
[TBL] [Abstract][Full Text] [Related]
19. High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.
Liau SS; Rocha F; Matros E; Redston M; Whang E
Cancer; 2008 Jul; 113(2):302-14. PubMed ID: 18473350
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma.
Li X; Xiao Y; Fan S; Xiao M; Wang X; Zhu X; Chen X; Li C; Zong G; Zhou G; Wan C
Hum Pathol; 2016 Nov; 57():182-192. PubMed ID: 27498060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
